Solid lipid nanoparticles containing vancomycin: Preparation, characterization and in vitro anti-Staphylococcus aureus biofilms activity

Gazzetta Medica Italiana Archivio per le Scienze Mediche

Volumn 168, Issue 2, 2009, Pages 89-93

  Fontana, G ^a   Schillaci, D ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Biofilms; SLN; Staphylococcus aureus; Vancomycin

Indexed keywords

ANTIBIOTIC AGENT; METHYLTHIAZOTETRAZOLIUM; PALMITIC ACID; PHOSPHATIDYLCHOLINE; SOLID LIPID NANOPARTICLE; TAUROCHOLIC ACID; TETRAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOFILM; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; IN VITRO STUDY; MICROBIOLOGICAL EXAMINATION; MICROEMULSION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; STAPHYLOCOCCUS AUREUS; ZETA POTENTIAL;

EID: 67651028059     PISSN: 03933660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Muller RH, Mader K, Gohla S. Solid Lipid Nanoparticles (SLN) for controlled drug delivery: a review of state of the art. Eur J Pharm Biopharm 2000;50:161-177
2. Heiati H, Tawashi R, Phillips NC. Solid lipid nanoparticles as drug carriers: Plasma stability and biodistribution of solid lipid nanoparticles containing the lipophilic prodrug 3′-azido-3′deoxythymidine palmitate in mice. Int J Pharm 1998;174:71-80. (Pubitemid 28486991)
3. Yang S, Lu FL, Cai Y, Zhu J, Liang BW, Yang CZ. Body distribution in mice of intravenously injected camptothecin solid lip nanoparticles and targeting effect on brain. J Controlled Release 1998;59:299-307. (Pubitemid 29238174)
4. Bondì ML, Fontana G, Carlisi B, Giammona G. Preparation and characterization of solid lipid nanoparticles containing cloricromene. Drug Delivery 2003;10:245-250 (Pubitemid 37494138)
5. Fontana G, Maniscalco L, Schillaci D, Cavallaro G, Giammona G. Drug delivery 2005;12:385-392
6. Yang S, Zhu J, Lu Y, Liang B, Yang C. Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharm Res 1999;16:751-757 (Pubitemid 29227107)
7. Hoffman LR et al. Aminoglycoside Antibiotics Induce Bacterial Biofilm Formation. Nature 2005; 436(7054): 1171-1175. (Pubitemid 41232296)
8. Mah TF et al. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 2003;426:306-310 (Pubitemid 37463151)
9. http://www.erc.montana.edu/biofilmbook/MODULE-07/Mod07-S04-2-Blue.htm
10. Gasco, MR. Solid lipid nanospheres from warm microemulsions. Pharm Techonol Eur 1997;9:52-58
11. Schillaci D, Petruso S, Sciortino V. 5,4,5,5′,5′-penta-bromo- 2-(2′ hydroxybenzoyl)pir-role: a potential lead compound as anti-gram-positive and anti-biofilm agent. Int J of Antimicrobial Agents 2005;25:338-340 (Pubitemid 40387281)